Annual Retained Earnings
-$469.73 M
-$126.64 M-36.91%
30 April 2024
Summary:
KalVista Pharmaceuticals annual retained earnings is currently -$469.73 million, with the most recent change of -$126.64 million (-36.91%) on 30 April 2024. During the last 3 years, it has fallen by -$301.89 million (-179.87%). KALV annual retained earnings is now -1534.51% below its all-time high of -$28.74 million, reached on 31 December 2012.KALV Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$510.17 M
-$40.44 M-8.61%
31 July 2024
Summary:
KalVista Pharmaceuticals quarterly retained earnings is currently -$510.17 million, with the most recent change of -$40.44 million (-8.61%) on 31 July 2024. Over the past year, it has dropped by -$114.12 million (-28.81%). KALV quarterly retained earnings is now -1382.36% below its all-time high of -$34.42 million, reached on 31 December 2013.KALV Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALV Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.9% | -28.8% |
| 3 y3 years | -179.9% | -150.6% |
| 5 y5 years | -407.9% | -382.6% |
KALV Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -179.9% | at low | -150.6% | at low |
| 5 y | 5 years | -407.9% | at low | -382.6% | at low |
| alltime | all time | -1534.5% | at low | -1382.4% | at low |
KalVista Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | - | -$510.17 M(+8.6%) |
| Apr 2024 | -$469.73 M(+36.9%) | -$469.73 M(+10.5%) |
| Jan 2024 | - | -$425.08 M(+7.3%) |
| Oct 2023 | - | -$396.05 M(+7.5%) |
| July 2023 | - | -$368.40 M(+7.4%) |
| Apr 2023 | -$343.08 M(+37.1%) | -$343.08 M(+8.3%) |
| Jan 2023 | - | -$316.78 M(+7.2%) |
| Oct 2022 | - | -$295.47 M(+8.1%) |
| July 2022 | - | -$273.22 M(+9.2%) |
| Apr 2022 | - | -$250.18 M(+10.7%) |
| Apr 2022 | -$250.18 M(+49.1%) | - |
| Jan 2022 | - | -$226.06 M(+11.0%) |
| Oct 2021 | - | -$203.59 M(+10.7%) |
| July 2021 | - | -$183.94 M(+9.6%) |
| Apr 2021 | -$167.84 M(+38.0%) | -$167.84 M(+9.8%) |
| Jan 2021 | - | -$152.88 M(+7.0%) |
| Oct 2020 | - | -$142.83 M(+7.9%) |
| July 2020 | - | -$132.41 M(+8.9%) |
| Apr 2020 | -$121.59 M(+31.5%) | -$121.59 M(+5.7%) |
| Jan 2020 | - | -$115.01 M(+8.8%) |
| Oct 2019 | - | -$105.72 M(+5.9%) |
| July 2019 | - | -$99.81 M(+7.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2019 | -$92.48 M(+29.0%) | -$92.48 M(+10.2%) |
| Jan 2019 | - | -$83.95 M(+4.9%) |
| Oct 2018 | - | -$79.99 M(+4.3%) |
| July 2018 | - | -$76.69 M(+7.0%) |
| Apr 2018 | -$71.66 M(+28.3%) | -$71.66 M(+0.9%) |
| Jan 2018 | - | -$71.00 M(+8.0%) |
| Oct 2017 | - | -$65.77 M(+8.2%) |
| July 2017 | - | -$60.78 M(+8.8%) |
| Apr 2017 | -$55.85 M(+49.9%) | -$55.85 M(+8.1%) |
| Jan 2017 | - | -$51.65 M(-41.9%) |
| Sept 2016 | - | -$88.96 M(+2.8%) |
| June 2016 | - | -$86.58 M(+9.3%) |
| Apr 2016 | -$37.25 M(-48.7%) | - |
| Mar 2016 | - | -$79.23 M(+9.1%) |
| Dec 2015 | -$72.62 M(+52.0%) | -$72.62 M(+8.5%) |
| Sept 2015 | - | -$66.96 M(+8.1%) |
| June 2015 | - | -$61.97 M(+17.0%) |
| Mar 2015 | - | -$52.96 M(+10.9%) |
| Dec 2014 | -$47.77 M(+38.8%) | -$47.77 M(+10.9%) |
| Sept 2014 | - | -$43.06 M(+25.1%) |
| Dec 2013 | -$34.42 M(+19.8%) | -$34.42 M |
| Dec 2012 | -$28.74 M | - |
FAQ
- What is KalVista Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual retained earnings year-on-year change?
- What is KalVista Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly retained earnings year-on-year change?
What is KalVista Pharmaceuticals annual retained earnings?
The current annual retained earnings of KALV is -$469.73 M
What is the all time high annual retained earnings for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual retained earnings is -$28.74 M
What is KalVista Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, KALV annual retained earnings has changed by -$126.64 M (-36.91%)
What is KalVista Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of KALV is -$510.17 M
What is the all time high quarterly retained earnings for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly retained earnings is -$34.42 M
What is KalVista Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, KALV quarterly retained earnings has changed by -$114.12 M (-28.81%)